Bayer Price to Sales Ratio 2010-2024 | BAYRY

Historical PS ratio values for Bayer (BAYRY) over the last 10 years. The current P/S ratio for Bayer as of February 10, 2025 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Bayer P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-12-27 4.98 inf
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $21.810B $51.553B
Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses. The company started reporting in three segments ' Pharmaceuticals, Consumer Health and Crop Science ' from the third quarter of 2019. Both Animal Health and Currenta were reported as discontinued operations in the quarter. The company acquired U.S. seed giant Monsanto in June, 2018. With the acquisition, Bayer now has the strongest portfolio of seed and crop protection products for a wide range of crops and indications, the best research and development platform and the leading digital farming business.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $826.256B 66.95
Novo Nordisk (NVO) Denmark $391.178B 26.50
Johnson & Johnson (JNJ) United States $369.594B 15.37
AbbVie (ABBV) United States $341.005B 19.07
Roche Holding AG (RHHBY) Switzerland $252.630B 0.00
AstraZeneca (AZN) United Kingdom $224.395B 17.61
Merck (MRK) United States $222.734B 11.52
Novartis AG (NVS) Switzerland $218.667B 13.70
Pfizer (PFE) United States $146.378B 8.31
Sanofi (SNY) $134.176B 12.71
Innoviva (INVA) United States $1.143B 9.51